[1]
2023. Safety and Preliminary Immunogenicity of Recombinant Hepatitis B (Bio Farma) Vaccine in Adults and Children: A Phase 1 Clinical Trial. Althea Medical Journal. 10, 4 (Dec. 2023), 242–251. DOI:https://doi.org/10.15850/amj.v10n4.3279.